ICD10monitor October 23, 2023
Timothy Powell, CPA, CHCP

The Centers for Medicare & Medicaid Services (CMS) is conducting a program that focuses on drug pricing negotiations, effective in 2026.

Here is a list of the drugs that CMS is including in their price negotiations:

Here’s a summarized timeline and breakdown of the upcoming events:

Fall 2023: Data Submission and Patient-Focused Listening Sessions

  • CMS invites each participating drug company with a selected drug for a meeting regarding data submission.
  • From Oct. 30 to Nov. 15, CMS holds patient-focused listening sessions for each selected drug.
  • These sessions will involve patients, beneficiaries, caregivers, consumer and patient organizations, and other interested parties.
  • The dates for these listening sessions are subject to change, including the possibility of postponement and/or cancellation.

Feb....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
CMS proposes new guardrails on Medicare Advantage prior authorizations, marketing
CMS finalizes new kidney transplant model: 10 things to know
CMS' proposed changes to Medicare Advantage: 10 things to know
Medicare Advantage Plans' Prior Auth Rules Would Be Made Public Under CMS Proposal
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule

Share This Article